two to four weeks following a progressive decline of expression.
Genetically-modified cells were identified as proximal tubular cells when the adenoviral vector was selectively perfused via the renal artery, while tubular cells from the papilla and medulla were selectively transduced by retrograde infusion of the viral vector. No obvious cytopathic effect was observed. We conclude that: (i) efficient gene transfer in renal tubular cells can be achieved by adenoviral vectors; (ii) the targeted cell population can be chosen through the route of administration.
The ability to deliver foreign gene and promoter elements into mammalian kidney would make it feasible to introduce biologically active peptide molecules into the kidney for therapeutic purposes or to address specific issues in experimental nephrology. For in vivo gene transfer, most attention has been focused on the use of viral vectors such as recombinant retroviruses or adenoviruses [reviewed in [1] , although nonviral vectors where the DNA is either naked or electrostatically complexed with inert substrates have recently demonstrated some potential [2, 3] . Recombinant retroviruses are currently the most widely used vectors for the introduction of genes into a broad variety of mammalian cells. However, the expression of the foreign gene needs its integration into the host genome which is dependent upon division of the targeted cell at the time of viral infection [4] . This precludes gene transduction in the kidney in which one is dealing with differentiated postmitotic cells. Although in a recent study [5] it was possible to induce, in adult rats, acute tubular cell replication after folic acid treatment, the direct injection into the kidney parenchyma, at this stage, of recombinant retroviruses carrying the 13-galactosidase reporter Received for publication December 14, 1993 and in revised form January 12, 1994 Accepted for publication January 13, 1994 © 1994 by the International Society of Nephrology gene resulted in only 0.5 to 1% transduction efficiency within the injected area.
An alternative approach for in vivo gene transfer into the kidney is the use of recombinant adenoviruses which have important advantages including: (i) they can be grown to extremely high titers; (ii) transfer and expression of the recombinant gene can be accomplished in non-dividing cells; (iii) they present a wide cell type tropism; and (iv) they can interact with various basement membranes. The general strategy is to produce recombinant adenovirus that are replication defective by virtue of deletions of Ela and Elb sequences.
To assess the suitability of recombinant adenoviral vectors for in vivo renal gene transfer, we used an El deleted adenovirus carrying the f3-galactosidase reporter gene [6] either selectively perfused into the left renal artery or applied by retrograde infusion into the left ureter of adult rats. Controlateral kidneys (right kidneys) were used as internal controls. We looked, at one to four weeks after gene delivery, for the presence of nuclear /3-galactosidase-expressing renal cells as well as for the possible renal cytotoxic effects of the recombinant adenoviral vector.
Methods
Experimental strategy A recombinant adenovirus which transduces, under the control of a Rous sarcoma virus (RSV) promoter, the lacZ gene (nlslacZ), coding for the Escherichia coli /3-galactosidase, was used as vector (Ad-f3gal). The lacZ gene was fused to a 21-amino acid nuclear localization sequence from simian virus 40 large tumor antigen which resulted in the specific and exclusive nuclear localization of the protein [7] . To test whether the adenovirus construct is able to direct /3-galactosidase expression in kidney, we selectively perfused the viral preparation into the left renal artery or ureter of 8-to 10-week-old Wistar rats (Iffa Credo, l'Arbresle, France). Animals were sacrificed at different time intervals from 7 to 30 days after the selective artery perfusions or ureteral infusions and genetically-modified cells were sought by enzyme histochemistry for nuclear E. coli f3-galactosidase. The right kidneys which have been excluded from the recombinant Ad-gal perfusion were used as internal controls. In addition, liver, lungs and bladder were monitored for possible spreading of the recombinant Ad-gal out of the perfused kidney. Urine samples from one experimental rat were collected before surgery and at different time intervals after 1220 Ad-j3gal retrograde infusion to evaluate for the presence of recombinant adenovirus.
Preparation of recombinant adenovirus A replication defective adenovirus based on Ad5 serotype was used in this study. The structure of Ad-pgal has been described previously [6] . In this virus, El sequences from 1.3 to 9.4 have been deleted and replaced with a minigene containing the Rous sarcoma virus long terminal repeat (RSV LTR), the lacZ gene with a nuclear localization sequence, and the SV4O early region polyadenylation signal; in addition E3 sequences spanning to 78.5 to 84.7 s have been deleted.
Stocks of recombinant viruses were prepared as follows. Cultures of L293 cells (4 x 600 cm2 plates-NUNC, Roskilde, Denmark) grown in DMEM containing 10% fetal calf serum (FCS), 100 U/nil penicfflin, and 100 tg/ml streptomycin were infected at 80% confluency with a multiplicity of infection (MOl) equal to 5 pfu per cell. Thirty hours following infection, cells were harvested. Pellets were resuspended in 10 ml of culture medium and subjected to four rounds of freeze-thaw, followed by separation of cell debris by centrifugation at 4,500 rpm for five minutes. Crude viral supernatants were layered onto a CsCl step gradient and centrifuged for one hour at 35,000 rpm. The intact viral particles were subjected to a second round of CsCI banding for 18 hours at 35,000 rpm. Viral particles were collected and extensively dialyzed against PBS containing 10% glycerol. Viral stocks were titered by infecting L293 cells with serial dilutions of the viral preparation for one hour at 37°C.
Twenty-four hours later, cells were fixed in PBS containing 1% formaldehyde and 0.5% glutaraldehyde and stained with X-Gal (see Cytochemical Analysis) for 18 hours at 30°C. The number of blue clones was evaluated to determine the viral titer. Viral stocks were frozen at -80°C in 10% glycerol until they were used. Immediately prior their use, viral stocks were diluted in PBS to 1 to 5 x 1010 pfu/ml. None of the stocks of virus used in the experiments contained detectable replication-competent viruses as evaluated on HeLa cells after extended cultivation [6] .
Asanguineous surgical perfusion of the kidney The left kidney of seven adult rats was exposed and its blood flow was interrupted for less than 10 minutes by clamping the aorta under the superior mesentenc artery and above the inferior mesenteric artery. This setting selectively excluded the left kidney without interrupting the blood flow through the controlateral right kidney. Depending on its implantation, the left adrenal artery was eventually ligated during this operation.
Using a 30 gauge needle, 1 x 1010 pfu/ml of recombinant Ad-f3gal, suspended in PBS in a final volume of 2 ml, was directly infused in the aorta nearby the left renal artery with a flow rate of 1 to 2 mI/mm. Recirculation of the infused Ad-f3gal was occasionally seen in the renal vein. After the recombinant Ad-/3gal had been administered, renal blood flow was reestablished and the kidney was checked for its homogeneous reperfusion.
Retrograde infusion
A PE 10 tubing (Beckton-Dickinson, Illinois, USA) was inserted into the left ureter of 7 adult rats and slided up into the pyelic cavity in which 300 1.d of a 5 x lO'° pfu/ml recombinant Ad-pgal solution were infused and incubated for five minutes. Pressure during the infusion procedure was not precisely recorded, however, it was done slowly without pyclic distention and subsequent hematuria. The catheter was then removed and urine flow was re-established. The controlateral right kidney was selectively infused with the vehicule solution and subsequently used as an internal control for X-Gal staining.
Cytochemical analysis
Gene transfer was monitored on cryostat sections as described [8] . The left and right kidneys were fixed in situ by perfusing a 4% paraformaldehyde-PBS solution. Mter removal, the kidneys were cut into 5 mm thick blocks. Blocks were either incubated overnight at 30°C with 5-bromo-4-chloro-3-indolyl j3-D-galactopyranoside (X-Gal; Sigma) substrate, pH 8.5 or immersed overnight in PBS with 30% sucrose at 4°C, frozen in isopentane, and used to prepare 10 jsm thick cryostat sections. The tissue sections were then incubated with X-Gal substrate and subsequently counterstained with hematoxylin. Samples from lungs, liver and bladder fixed in 4% paraformaldehyde were monitored identically for the presence of nuclear-/3-galactosidase-expressing cells.
Immunocytochemical colocalization of nuclear /3-galactosidase and the gp-90 brush border antigen specific for the proximal tubular cells [9] was performed as follows. After X-Gal staining of the cryostat sections, a mouse anti-gp9O monoclonal antibody was incubated at a dilution of 1:1000 in PBS-5% low fat milk on kidney sections previously incubated with 3% final H202 to inactivate the endogenous peroxidase activity. A 1:1000 diluted rabbit anti-mouse antibody (Amersham) coupled to peroxidase was used for staining using 0.001% DAB (Amersham) and cobalt chloride at 0.03% final concentration. For routine histology, the tissues were fixed in 10% formaldehyde prior to sectioning and staining.
Recovery of adenovirus from urine samples To assess the ability of transduced kidneys to express recombinant adenovirus, urines samples were collected at timed intervals following the left ureter infusion of Rat #11 (Table 1 ). All fractions were immediately evaluated for the presence of recombinant virus on L293 cells. Cells were assayed for nuclear f3-galactosidase activity by X-Gal staining and results expressed as number of positive cells per ml and mg of creatininuria.
Creatinine was measured as described [10] .
Results
Renal artery perfusion No macroscopic change was found immediately after the Ad-pgal perfusion and at the time of sacrifices (7, 15 , and 30 days). Kidneys appeared homogeneously perfused and not different from the controlateral untransduced kidneys. Routine histology indicated that left kidneys structures were conserved and undistinguishable from the controlateral kidneys at 7, 15 and 30 days after the transduction procedure (data not shown). Nuclear J3-galactosidase activity could be readily detected on kidney blocks for up to 15 days after recombinant Ad-/3gal perfusion, exclusively limited to the cortex in an heterogenous fashion (Fig. 1A) . Table 1 shows an estimation of the positive cells within the cortex area, scored on X-Gal-stained cryostat (Fig. 2) . The controlateral kidney never contained j3-galactosidase-positive cells (Figs. lb and 4) . Counterstaining the kidney sections with a monoclonal antibody recognizing gp 90, a specific antigen on the proximal tubular brush border [9] , disclosed that j3-galactosidase-positive cells were exclusively proximal tubular cells (Fig. 3) .
Since the Ad-/3gal can infect a number of different cell types and the delivery system used here does not preclude the infection of other tissues, we evaluated whether other distant organs were transduced by this gene delivery procedure. Liver and lungs from animals #3 and #4 were examined for the expression of /3-galactosidase-positive cells by X-Gal staining. None could be detected (data not shown), suggesting that the first passage through the kidney via the renal artery route resulted in the vast majority of the virus being taken up by the proximal tubular cells.
Retrograde infusion Since ureteral retrograde catheterization is a common clinical procedure, we were willing to document the possibility of transferring foreign gene in situ into kidney cells via this simple and highly selective route. Among the seven rats that we have infused and further investigated at different time intervals (7, 10 and 15 days), macroscopic view and routine histology did not show any evidence of hemodynamic and cytotoxic effects related to the use of the adenoviral vector via this retrograde procedure. Renal structures remained unchanged even soon after the retrograde infusion of Ad-f3gal (7 days) and no significant difference was noted when compared to the internal controls represented by the controlateral kidneys infused with the vehicule buffer only. Nuclear /3-galactosidase activity could be easily detected on kidney blocks seven days after recombinant Ad-f3gal perfusion (data not shown), exclusively limited to the papillas with an extremely high intensity in some areas for rat #9. Table 1 shows an estimation of the positive cells within the papillary/medullary regions, scored on sections of experimental kidneys. A high (+ + +) fraction of transduced cells was found in rat #9, sacrificed seven days after Ad-/3gal infusion (Fig. 5) . Rats #10 and #11 exhibited an intermediate (+ +) level of genetically modified cells within the papilla and medulla areas when examined 7 and 10 days after retrograde infusion. In contrast, only few (+) cells were found to be transduced in rats #8 and #12 sacrificed at 7 and 15 days, respectively. Finally, two animals (rats #13 and #14) were found negative on several cryostat sections screened.
Despite heterogeneity in gene transfer efficiency in this group, individualized analysis revealed that the /3-galactosidase-expressing cells appeared essentially limited to the medulla and papilla, involving the tubular cells with no evidence of any gene transfer into glomerular structures as well as the interstitial compartment (Figs. S and 6) .
After gene delivery, urine was evaluated for the presence of recombinant Ad-/3gal using L293 cells. In rat #11, which exhibited transduced medulla and papilla (Table 1) with no detectable /3-galactosidase-positive cells on bladder sections, the concentration of virus in the urine samples dropped precipitously during the first two days following the retrograde gene transfer procedure (3750 pfu/ml!hr mg1 creatininuria at day 1, 240 pfu/ml/hr mgt creatininuria at day 2) and stabilized within barely detectable levels (<10 pfu/ml).
Discussion
We show that recombinant adenovirus vector can efficiently transduce kidney cells upon selective perfusion of the renal artery or retrograde infusion via the ureter without detectable tissue injury. The present work illustrates that the kidney is a target for gene transfer to be added to the increasing list of permissive organs to recombinant adenoviruses [reviewed in 1, 11] . Efficient expression was observed in short-term experiments (up to 15 days) with intense staining of the /3-galactosidase reporter gene in either the cortex or medulla depending on the route of administration. Using the renal artery perfusion route, gene transfer occurred exclusively in proximal tubular cells as evidenced by colocalization of nuclear /3-galactosidase
Figs. 1-6. Histochemical staining of kidneys from rat #3 (Figs. Ia, lb, 2, 3 and 4) and rat #9 (Figs. Sand 6 ). X-Gal staining of 5 mm thick blocks from the left experimental kidney la) and from the right control kidney (Fig. lb) examined with a binocular microscope (7.5x). Cryostat sections of the Ad-f3gal-perfused left kidney stained with X-Gal and either counterstained with hematoxylin (Fig. 2, 75 x) or incubated with a monoclonal antibody against a proximal brush border antigen, gp9O, revealed by an anti-mouse IgG antibody peroxidase-labeled (Fig. 3, 140X) . Arrows indicate the nuclear 13-galactosidase. X-gal staining and anti gp9O labelling on the control right kidney (Fig. 4, l4OX) . Distribution of the genetically-modified tubular cells in the papilla of rat #9 (Figs. 5, x25 and 6, 250x) .
activity with gp9O-positive brush borders throughout the cortex. No 3-galactosidase transduced cells could be detected in glomeruli, interstitium as well as in the medulla and papilla.
Conversely, using the retrograde route through the ureter led to highly efficient gene transfer strictly targeted to medullar and papillar epithelial cells, possibly collecting tubular cells, at least in part. However, it has to be emphasized that in both routes of administration gene transfer occurred with a striking heterogeneity. For instance, as seen Figure 5 , the p-galactosidasepositive papilla is so intense that diffusion of X-Gal precipitates made the quantification of cell types within large, highly expressing clusters difficult as the remaining papilla in the vicinity is almost devoid of transduced-positive cells. Similarly, at the cortex level, when using the renal artery perfusion route, areas with a high density of /3-galactosidase-positive cells alternate with areas with negative to low density of transduced proximal tubular cells (Fig. 2) . This high heterogeneity may be related to: (i) the low perfusion rate; (ii) the particular renal artery network throughout the cortex; (iii) a dilution factor increasing as the adenoviral perfusate floods the kidney; and (iv) the lack of a mixing chamber upstream of the kidney. Whatever explanation prevails, such heterogeneity renders precise quantification impossible and requires optimization and standardization of the gene transfer procedures. Despite these pitfalls, the recombinant adenovirus vector appeared more efficient than that observed in experiments carried out by direct injection into the renal cortex of a retroviral vector suspension carrying the /3-galactosidase reporter gene [5] . In these experiments, less than 1% of tubulescontaining positive cells were found exclusively within the injection site. Although this latter study suggested that expression of the transferred reporter gene could be detected at least seven weeks, it required the induction of an acute nephrotoxic injury prior the use of the retroviral vector. Conversely, using Ad-f3gal vector did not required any invasive procedure nor had any cytotoxic effect at the viral titer used (1 x 1010 pfulml) . However, the number of genetically-modified tubular cells appeared to decrease over time. Despite the unconveniency to follow individual animals over time using an intracellular marker such as /3-galactosidase, the reproducibility of transduction efficiency allowed the evaluation of individual animals at different time points after gene delivery even though ureteral retrograde infusion appeared more difficult to control. At day 15, using the retrograde infusion, only few (+) /3-galactosidaseexpressing tubular cells were found within the medulla and papilla as compared to intermediate (+ +) or high (+ + +) levels of transduction one week after gene transfer. By 30 days after selective perfusion of the renal artery, only rare (+) transduced proximal tubular cells were detected in individual animals as intermediate (+ +) to high (+ + +) levels of transduction were found two weeks after gene delivery. This progressive decrease may be related to: (i) experimental variations between experimental kidneys; (ii) inactivation at the host cell level of the RSV LTR promoter used in the Ad-/3gal construct as already documented in vivo with other viral promoters in fibroblasts [12] , [13] ; (iii) since adenoviral genome does not integrate into the host genome [14] , the DNA may be gradually lost from tubular cells over time related to the low rate cell replication found in healthy adult mammalian kidney [15] . Indeed, in vivo persistency of episomal expression from adenoviral vectors is morelikely correlated to the turnover of the targeted cell. For instance, sustained expression of foreign gene in muscle [16] , neurons, glia [17] have been reported for several months whereas rapid decrease of the transgene expression (within few weeks) was observed in transduced liver [18] and lungs [19] . It is unlikely that transduced renal cells are selectively killed in vivo because with a high transduction efficiency by either route in short-term experiments, there should be evidence of tubular regeneration in transduced animals, which was not seen on histopathologic sections. However, these important issues will need to be addressed experimentally.
Refinement of in vivo strategies using higher titers, larger volumes of adenoviral solution, various timing of viral challenges could further significantly enhance gene transfer efficiency. For instance, using higher adenoviral titers would certainly represent a potential benefit in this model for two reasons: (i) recent studies have shown that gene transfer efficiency in vitro as well as in vivo, in liver [18] , lung [20] , and muscle cells [16] is directly correlated to the titre of the recombinant adenovirus vector within a range of 1 x iO to 1 x 1012 pfu/ml; (ii) tubular basement membrane may act on one hand as an anatomical barrier requiring higher concentrations of adenoviral vector, on the other hand as a relative protection against recombinant adenovirus-induced cytopathic effect such as described in the liver when directly challenged to titers over 7 x 1010 pfulml [18] , or 1 x l0 pfu/ml in the brain [21] .
The selective perfusion of the renal artery and the retrograde ureter infusion methods that led to quantitative transduction of tubular cells did not show detectable adenoviral leakage out of the kidney to other tissues such as the liver, lung and bladder. This suggest that either the virus is highly nephrotropic by these routes of delivery and/or that titers of approximately 1 x iO'°p fu/ml used in the present work for all experimental animals may not represent enough viral particles to saturate renal receptors. Whatever explanation prevails, it is worth noting that basement membranes do not preclude infection by the recombinant adenovirus of tubular epithelial cells via the vascular route. The persistence of recombinant adenovirus in urine samples of rat #11, even at extremely low titer (<10 pfu/ml), 10 days after retrograde gene delivery was unexpected. It is unlikely that rat tubular cells are supporting low levels of virus production because rat cells are not expected to trans-complement replication-defective adenoviruses. It is more likely that the virus recovered in the urine samples represents residual viruses from the initial retrograde infusion. Such residual viral activity was also recently reported by Engelhardt et al [20] in effluents of human bronchial xenograft infused with a similar vector, although in this latter case, complementation by the human cells could be an additional explanation.
Despite that nuclear f3-galactosidase expression decreases over time in the experimental conditions described in the present work, the kidney represents an attractive target for gene transfer for several reasons: (i) one of the two kidneys can be genetically-modified selectively; (ii) depending on the route of administration, one can address specific questions related to the target cell or area involved; (iii) the adenovirus vector could be a useful experimental tool to change or add the expression of genes acutely in the kidney through simple non invasive procedures on a large variety of laboratory animals; (iv) if the secretion of the transgene product is expected at the basolateral side of the tubular cells, the kidney may represent an ectopic source of a therapeutic peptide directly available in the circulation [22] .
Finally, the possibility of repetitive gene delivery for extended effects, the use of alternative promoters and the expression of therapeutic gene should be investigated.
